These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31028803)

  • 1. TAK1 may promote the development of diabetic nephropathy by reducing the stability of SnoN protein.
    Wang Y; Mao Y; Zhang X; Liu H; Peng W; Liang L; Shi M; Xiao Y; Zhang Y; Zhang F; Yan R; Guo B
    Life Sci; 2019 Jul; 228():1-10. PubMed ID: 31028803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ski-related novel protein suppresses the development of diabetic nephropathy by modulating transforming growth factor-β signaling and microRNA-21 expression.
    Wang Y; Liu L; Peng W; Liu H; Liang L; Zhang X; Mao Y; Zhou X; Shi M; Xiao Y; Zhang F; Zhang Y; Liu L; Yan R; Guo B
    J Cell Physiol; 2019 Aug; 234(10):17925-17936. PubMed ID: 30847937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smad2 and Smad3 play antagonistic roles in high glucose-induced renal tubular fibrosis via the regulation of SnoN.
    Wang Y; Zhang X; Mao Y; Liang L; Liu L; Peng W; Liu H; Xiao Y; Zhang Y; Zhang F; Shi M; Liu L; Guo B
    Exp Mol Pathol; 2020 Apr; 113():104375. PubMed ID: 31917288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SnoN upregulation ameliorates renal fibrosis in diabetic nephropathy.
    Liu L; Shi M; Wang Y; Zhang C; Su B; Xiao Y; Guo B
    PLoS One; 2017; 12(3):e0174471. PubMed ID: 28350874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxymatrine Inhibits Renal Tubular EMT Induced by High Glucose via Upregulation of SnoN and Inhibition of TGF-β1/Smad Signaling Pathway.
    Liu L; Wang Y; Yan R; Li S; Shi M; Xiao Y; Guo B
    PLoS One; 2016; 11(3):e0151986. PubMed ID: 27010330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of miR-23a inhibits high glucose-induced EMT and renal fibrogenesis by up-regulation of SnoN.
    Xu H; Sun F; Li X; Sun L
    Hum Cell; 2018 Jan; 31(1):22-32. PubMed ID: 28707079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMP-7 enhances SnoN mRNA expression in renal tubular epithelial cells under high-glucose conditions.
    Wang Y; Xiao Y; Li S; Shi L; Liu L; Zhang Y; Shi M; Guo B
    Mol Med Rep; 2017 Sep; 16(3):3308-3314. PubMed ID: 28765970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BMP-7 ameliorates partial epithelial-mesenchymal transition by restoring SnoN protein level via Smad1/5 pathway in diabetic kidney disease.
    Peng W; Zhou X; Xu T; Mao Y; Zhang X; Liu H; Liang L; Liu L; Liu L; Xiao Y; Zhang F; Li S; Shi M; Zhou Y; Tang L; Wang Y; Guo B
    Cell Death Dis; 2022 Mar; 13(3):254. PubMed ID: 35314669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BMP-7 inhibits renal fibrosis in diabetic nephropathy via miR-21 downregulation.
    Liu L; Wang Y; Yan R; Liang L; Zhou X; Liu H; Zhang X; Mao Y; Peng W; Xiao Y; Zhang F; Liu L; Shi M; Guo B
    Life Sci; 2019 Dec; 238():116957. PubMed ID: 31655195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-130a-3p inhibition protects against renal fibrosis in vitro via the TGF-β1/Smad pathway by targeting SnoN.
    Ai K; Zhu X; Kang Y; Li H; Zhang L
    Exp Mol Pathol; 2020 Feb; 112():104358. PubMed ID: 31836508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FSP1-specific SMAD2 knockout in renal tubular, endothelial, and interstitial cells reduces fibrosis and epithelial-to-mesenchymal transition in murine STZ-induced diabetic nephropathy.
    Loeffler I; Liebisch M; Allert S; Kunisch E; Kinne RW; Wolf G
    Cell Tissue Res; 2018 Apr; 372(1):115-133. PubMed ID: 29209813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regulatory effect of berberine on unbalanced expressions of renal tissue TGF-beta1/SnoN and smad signaling pathway in rats with early diabetic nephropathy].
    Liu S; Yu N; Zhang XL; Chen XQ; Tang LQ
    Zhongguo Zhong Yao Za Zhi; 2012 Dec; 37(23):3604-10. PubMed ID: 23477149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanism of smurf2 in regulating the expression of SnoN in diabetic nephropathy.
    Xu Z; Diao Z; Liu R; Liu W
    Mol Med Rep; 2017 May; 15(5):2560-2566. PubMed ID: 28447757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SnoN as a key regulator of the high glucose-induced epithelial-mesenchymal transition in cells of the proximal tubule.
    Liu R; Wang Y; Xiao Y; Shi M; Zhang G; Guo B
    Kidney Blood Press Res; 2012; 35(6):517-28. PubMed ID: 22813962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood glucose control contributes to protein stability of Ski-related novel protein N in a rat model of diabetes.
    Liang L; Li S; Liu H; Mao Y; Liu L; Zhang X; Peng W; Xiao Y; Zhang F; Shi M; Wang Y; Guo B
    Exp Ther Med; 2021 Nov; 22(5):1341. PubMed ID: 34630695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-β1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b.
    Wang B; Jha JC; Hagiwara S; McClelland AD; Jandeleit-Dahm K; Thomas MC; Cooper ME; Kantharidis P
    Kidney Int; 2014 Feb; 85(2):352-61. PubMed ID: 24088962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quercetin inhibits the mTORC1/p70S6K signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in diabetic nephropathy.
    Lu Q; Ji XJ; Zhou YX; Yao XQ; Liu YQ; Zhang F; Yin XX
    Pharmacol Res; 2015 Sep; 99():237-47. PubMed ID: 26151815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The proteasome inhibitor, MG132, attenuates diabetic nephropathy by inhibiting SnoN degradation in vivo and in vitro.
    Huang W; Yang C; Nan Q; Gao C; Feng H; Gou F; Chen G; Zhang Z; Yan P; Peng J; Xu Y
    Biomed Res Int; 2014; 2014():684765. PubMed ID: 25003128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAK1 MAPK kinase kinase mediates transforming growth factor-beta signaling by targeting SnoN oncoprotein for degradation.
    Kajino T; Omori E; Ishii S; Matsumoto K; Ninomiya-Tsuji J
    J Biol Chem; 2007 Mar; 282(13):9475-9481. PubMed ID: 17276978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Bone Marrow Mesenchymal Stem Cells on Plasminogen Activator Inhibitor-1 and Renal Fibrosis in Rats with Diabetic Nephropathy.
    Lang H; Dai C
    Arch Med Res; 2016 Feb; 47(2):71-7. PubMed ID: 27018336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.